-+ 0.00%
-+ 0.00%
-+ 0.00%

Alterity Therapeutics presents MSA program update at medical conferences

PUBT·05/07/2026 10:13:57
Listen to the news
Alterity Therapeutics presents MSA program update at medical conferences
  • Alterity Therapeutics scheduled to present Multiple System Atrophy data at ISMRM 2026 in Cape Town on May 12, 2026.
  • Poster presentation at MDSANZ Scientific Meeting in Sydney set for May 15-17, 2026, covering results from a randomized, double-blind, placebo-controlled ATH434 study using CSF NfL as covariate.
  • CEO David Stamler to give oral update on ATH434 clinical program and Phase 3 planning at MSA Symposium 2026 in London on May 18, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alterity Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-015330), on May 07, 2026, and is solely responsible for the information contained therein.